Home » Topics » BioWorld Science

BioWorld Science
RSS

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics

March 17, 2022

New lysine-specific demethylase 5B inhibitors identified at FibroGen

March 17, 2022

Shengke Pharmaceuticals discovers FLT inhibitors

March 17, 2022

NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC

March 17, 2022

LinKinVax and GTP Bioways collaborate on second-generation pan-coronavirus vaccine

March 16, 2022

Study reports insights into organ-specific aging

March 16, 2022

Satellos advances compounds to modulate muscle stem cell polarity for Duchenne muscular dystrophy

March 16, 2022

CD19/CD22 targeting bivalent CAR-T therapy show efficacy in leukemia models

March 16, 2022

Serum interleukin level changes reflect severe depression and PTSD

March 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...